105 related articles for article (PubMed ID: 31212223)
1. Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.
Wendt R; Gao Y; Miller BJ
Cancer Epidemiol; 2019 Aug; 61():119-123. PubMed ID: 31212223
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.
Duchman KR; Gao Y; Miller BJ
Cancer Epidemiol; 2015 Aug; 39(4):593-9. PubMed ID: 26002013
[TBL] [Abstract][Full Text] [Related]
3. The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma.
Cao Z; Zhang Y; Xu Q; Yu X; Liu X; Dai M
Technol Cancer Res Treat; 2021; 20():15330338211066195. PubMed ID: 34918558
[No Abstract] [Full Text] [Related]
4. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study.
Song K; Song J; Lin K; Chen F; Ma X; Jiang J; Li F
Int Orthop; 2019 Aug; 43(8):1983-1991. PubMed ID: 31127366
[TBL] [Abstract][Full Text] [Related]
6. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
7. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.
Mirabello L; Troisi RJ; Savage SA
Cancer; 2009 Apr; 115(7):1531-43. PubMed ID: 19197972
[TBL] [Abstract][Full Text] [Related]
10. A population-based propensity-matched study of regional dissections in patients with metastatic osteosarcoma.
Wang W; Ding H; Sun Z; Jin C; Zhu Y; Wang X
J Orthop Surg Res; 2020 Mar; 15(1):107. PubMed ID: 32169092
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors in Patients With Osteosarcoma With the Surveillance, Epidemiology, and End Results Database.
Fu P; Shi Y; Chen G; Fan Y; Gu Y; Gao Z
Technol Cancer Res Treat; 2020; 19():1533033820947701. PubMed ID: 32787692
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database.
Miller BJ; Cram P; Lynch CF; Buckwalter JA
J Bone Joint Surg Am; 2013 Jul; 95(13):e89. PubMed ID: 23824394
[TBL] [Abstract][Full Text] [Related]
13. Low income and rural county of residence increase mortality from bone and joint sarcomas.
Cheung MR
Asian Pac J Cancer Prev; 2013; 14(9):5043-7. PubMed ID: 24175773
[TBL] [Abstract][Full Text] [Related]
14. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
[TBL] [Abstract][Full Text] [Related]
15. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
16. Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.
Wu J; Sun H; Li J; Guo Y; Zhang K; Lang C; Zou C; Ma H
Cancer Med; 2018 Aug; 7(8):3652-3661. PubMed ID: 29992762
[TBL] [Abstract][Full Text] [Related]
17. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
18. Marital Status and Survival in Osteosarcoma Patients: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Qiu S; Tao L; Zhu Y
Med Sci Monit; 2019 Nov; 25():8190-8203. PubMed ID: 31672959
[TBL] [Abstract][Full Text] [Related]
19. Effect of rural and urban geography on larynx cancer incidence and survival.
Zuniga SA; Lango MN
Laryngoscope; 2018 Aug; 128(8):1874-1880. PubMed ID: 29238975
[TBL] [Abstract][Full Text] [Related]
20. Rural/urban residence and childhood and adolescent cancer survival in the United States.
Delavar A; Feng Q; Johnson KJ
Cancer; 2019 Jan; 125(2):261-268. PubMed ID: 30311635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
